CardioLync Joins NVIDIA Inception

JERUSALEM - Aug. 12, 2021 - PRLog -- CardioLync is focused on improving outcomes for chronic care patients through effective interdisciplinary care coordination.  CardioLync's web accessible software application uses its proprietary and secure social network technology; which enables fluent communication and diagnostic image sharing among different medical specialists, imaging technicians, nurses, and patients; improving workflow efficiency and coordinated clinical decision making among these stakeholders across departments and institutions and with patient control.

NVIDIA Inception will allow CardioLync to begin developing an expansive suite of AI functions that will help drive forward product usage through go-to-market support, training, and technology assistance. The program will also offer CardioLync the opportunity to collaborate with industry-leading experts and other AI-driven organizations.

Jeremy Kagan, CEO of CardioLync said, "The CardioLync team is grateful to NVIDIA for bringing us into their Inception Program. We are expanding our product's functionality with machine learning and natural language processing algorithms that will help users – doctors and patients alike- to identify previously undiagnosed conditions that chronic disease patients may be suffering from. Predictive diagnosis is a growing area that demands leading edge data science and fast and accurate deep data processing capabilities. With NVIDIA's support and advice, CardioLync is confident that we will succeed in developing new features that will become part of the standard of care for doctors around the world."

NVIDIA Inception is a program that helps startups during critical stages of product development, prototyping and deployment. Every Inception member gets a custom set of ongoing benefits, such as NVIDIA Deep Learning Institute (https://www.nvidia.com/en-us/deep-learning-ai/education/?...) credits, marketing support, and technology assistance, which provides startups with the fundamental tools to help them grow.

About CardioLync
CardioLync facilitates a unified view of a chronic disease patient's condition across specialties, across hospitals, and across regions. CardioLync's pioneering Diagnostic Modality Interface Portal(tm) (DMIP) is a web accessible software technology which enables fluent communication and native image access at the point of care among different medical specialists, imaging technicians, nurses, and patients; improving workflow efficiency and coordinated clinical decision making among these stakeholders; while providing patient control and engagement.  Using DMIP, a hospital can smoothly extend the reach of its specialty and sub-specialty centers of excellence to remote satellite medical centers across the country and overseas.

Diagnostic Modality Interface Portal and DMIP are trademarks of CardioLync, Inc.